Literature DB >> 29802550

Building the Case for Localized Approaches to HIV: Structural Conditions and Health System Capacity to Address the HIV/AIDS Epidemic in Six US Cities.

D Panagiotoglou1, M Olding1, B Enns1, D J Feaster2, C Del Rio3, L R Metsch4, R M Granich5, S A Strathdee6, B D L Marshall7, M R Golden8, S Shoptaw9, B R Schackman10, B Nosyk11,12.   

Abstract

Since the discovery of the secondary preventive benefits of antiretroviral therapy, national and international governing bodies have called for countries to reach 90% diagnosis, ART engagement and viral suppression among people living with HIV/AIDS. The US HIV epidemic is dispersed primarily across large urban centers, each with different underlying epidemiological and structural features. We selected six US cities, including Atlanta, Baltimore, Los Angeles, Miami, New York, and Seattle, with the objective of demonstrating the breadth of epidemiological and structural differences affecting the HIV/AIDS response across the US. We synthesized current and publicly-available surveillance, legal statutes, entitlement and discretionary funding, and service location data for each city. The vast differences we observed in each domain reinforce disparities in access to HIV treatment and prevention, and necessitate targeted, localized strategies to optimize the limited resources available for each city's HIV/AIDS response.

Entities:  

Keywords:  Epidemiology; HIV; Health system; Policy

Mesh:

Substances:

Year:  2018        PMID: 29802550      PMCID: PMC6076864          DOI: 10.1007/s10461-018-2166-6

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  35 in total

1.  Criminalization of HIV transmission and exposure: research and policy agenda.

Authors:  Zita Lazzarini; Carol L Galletly; Eric Mykhalovskiy; Dini Harsono; Elaine O'Keefe; Merrill Singer; Robert J Levine
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

2.  Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Holly Hagan; David C Perlman; Salaam Semaan
Journal:  Am J Public Health       Date:  2011-05-12       Impact factor: 9.308

3.  Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.

Authors:  A David Paltiel; Rochelle P Walensky; Bruce R Schackman; George R Seage; Lauren M Mercincavage; Milton C Weinstein; Kenneth A Freedberg
Journal:  Ann Intern Med       Date:  2006-12-05       Impact factor: 25.391

4.  On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.

Authors:  Jean-Michel Molina; Catherine Capitant; Bruno Spire; Gilles Pialoux; Laurent Cotte; Isabelle Charreau; Cecile Tremblay; Jean-Marie Le Gall; Eric Cua; Armelle Pasquet; François Raffi; Claire Pintado; Christian Chidiac; Julie Chas; Pierre Charbonneau; Constance Delaugerre; Marie Suzan-Monti; Benedicte Loze; Julien Fonsart; Gilles Peytavin; Antoine Cheret; Julie Timsit; Gabriel Girard; Nicolas Lorente; Marie Préau; James F Rooney; Mark A Wainberg; David Thompson; Willy Rozenbaum; Veronique Doré; Lucie Marchand; Marie-Christine Simon; Nicolas Etien; Jean-Pierre Aboulker; Laurence Meyer; Jean-François Delfraissy
Journal:  N Engl J Med       Date:  2015-12-01       Impact factor: 91.245

5.  Human immunodeficiency virus transmission at each step of the care continuum in the United States.

Authors:  Jacek Skarbinski; Eli Rosenberg; Gabriela Paz-Bailey; H Irene Hall; Charles E Rose; Abigail H Viall; Jennifer L Fagan; Amy Lansky; Jonathan H Mermin
Journal:  JAMA Intern Med       Date:  2015-04       Impact factor: 21.873

Review 6.  An Overview of Research and Evaluation Designs for Dissemination and Implementation.

Authors:  C Hendricks Brown; Geoffrey Curran; Lawrence A Palinkas; Gregory A Aarons; Kenneth B Wells; Loretta Jones; Linda M Collins; Naihua Duan; Brian S Mittman; Andrea Wallace; Rachel G Tabak; Lori Ducharme; David A Chambers; Gila Neta; Tisha Wiley; John Landsverk; Ken Cheung; Gracelyn Cruden
Journal:  Annu Rev Public Health       Date:  2017-03-20       Impact factor: 21.981

7.  Healthcare Coverage for HIV Provider Visits Before and After Implementation of the Affordable Care Act.

Authors:  Stephen A Berry; John A Fleishman; Baligh R Yehia; Laura W Cheever; Heather Hauck; P Todd Korthuis; W Christopher Mathews; Jeanne Keruly; Ank E Nijhawan; Allison L Agwu; Charurut Somboonwit; Richard D Moore; Kelly A Gebo
Journal:  Clin Infect Dis       Date:  2016-05-03       Impact factor: 9.079

8.  Ensuring access to treatment for HIV infection.

Authors:  Laura W Cheever; Christine Lubinski; Michael Horberg; Judith L Steinberg
Journal:  Clin Infect Dis       Date:  2007-12-15       Impact factor: 9.079

9.  Expanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United Kingdom.

Authors:  Elisa F Long; Roshni Mandalia; Sundhiya Mandalia; Sabina S Alistar; Eduard J Beck; Margaret L Brandeau
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

10.  Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.

Authors:  Hasina Samji; Angela Cescon; Robert S Hogg; Sharada P Modur; Keri N Althoff; Kate Buchacz; Ann N Burchell; Mardge Cohen; Kelly A Gebo; M John Gill; Amy Justice; Gregory Kirk; Marina B Klein; P Todd Korthuis; Jeff Martin; Sonia Napravnik; Sean B Rourke; Timothy R Sterling; Michael J Silverberg; Stephen Deeks; Lisa P Jacobson; Ronald J Bosch; Mari M Kitahata; James J Goedert; Richard Moore; Stephen J Gange
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

View more
  18 in total

Review 1.  Structural Design and Data Requirements for Simulation Modelling in HIV/AIDS: A Narrative Review.

Authors:  Xiao Zang; Emanuel Krebs; Linwei Wang; Brandon D L Marshall; Reuben Granich; Bruce R Schackman; Julio S G Montaner; Bohdan Nosyk
Journal:  Pharmacoeconomics       Date:  2019-10       Impact factor: 4.981

2.  Can the United States Achieve Human Immunodeficiency Virus Epidemic Control? A New Initiative Offers Hope.

Authors:  Carlos Del Rio; Wendy S Armstrong; James Curran
Journal:  Clin Infect Dis       Date:  2019-09-27       Impact factor: 9.079

3.  Prevalence and correlates of HIV testing and HIV-positive status in the US: Results from the National Epidemiological Survey on Alcohol and Related Conditions III (NESARC-III).

Authors:  Carlos Blanco; Melanie M Wall; Wilson M Compton; Shoshana Kahana; Tianshu Feng; Tulshi Saha; Jennifer C Elliott; H Irene Hall; Bridget F Grant
Journal:  J Psychiatr Res       Date:  2018-08-03       Impact factor: 4.791

4.  Prioritizing Additional Data Collection to Reduce Decision Uncertainty in the HIV/AIDS Response in 6 US Cities: A Value of Information Analysis.

Authors:  Xiao Zang; Hawre Jalal; Emanuel Krebs; Ankur Pandya; Haoxuan Zhou; Benjamin Enns; Bohdan Nosyk
Journal:  Value Health       Date:  2020-10-03       Impact factor: 5.725

5.  Can the 'Ending the HIV Epidemic' initiative transition the USA towards HIV/AIDS epidemic control?

Authors:  Xiao Zang; Emanuel Krebs; Cassandra Mah; Jeong E Min; Brandon D L Marshall; Daniel J Feaster; Bruce R Schackman; Lisa R Metsch; Steffanie A Strathdee; Czarina N Behrends; Bohdan Nosyk
Journal:  AIDS       Date:  2020-12-01       Impact factor: 4.177

6.  Combined estimation of disease progression and retention on antiretroviral therapy among treated individuals with HIV in the USA: a modelling study.

Authors:  Linwei Wang; Emanuel Krebs; Jeong E Min; W Christopher Mathews; Ank Nijhawan; Charurut Somboonwit; Judith A Aberg; Richard D Moore; Kelly A Gebo; Bohdan Nosyk
Journal:  Lancet HIV       Date:  2019-07-11       Impact factor: 12.767

7.  Evaluating the population-level effects of overdose prevention sites and supervised consumption sites in British Columbia, Canada: Controlled interrupted time series.

Authors:  Dimitra Panagiotoglou
Journal:  PLoS One       Date:  2022-03-22       Impact factor: 3.240

8.  Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities.

Authors:  Emanuel Krebs; Xiao Zang; Benjamin Enns; Jeong E Min; Czarina N Behrends; Carlos Del Rio; Julia C Dombrowski; Daniel J Feaster; Kelly A Gebo; Brandon D L Marshall; Shruti H Mehta; Lisa R Metsch; Ankur Pandya; Bruce R Schackman; Steffanie A Strathdee; Bohdan Nosyk
Journal:  J Infect Dis       Date:  2020-09-02       Impact factor: 5.226

9.  Ending the HIV epidemic in the USA: an economic modelling study in six cities.

Authors:  Bohdan Nosyk; Xiao Zang; Emanuel Krebs; Benjamin Enns; Jeong E Min; Czarina N Behrends; Carlos Del Rio; Julia C Dombrowski; Daniel J Feaster; Matthew Golden; Brandon D L Marshall; Shruti H Mehta; Lisa R Metsch; Ankur Pandya; Bruce R Schackman; Steven Shoptaw; Steffanie A Strathdee
Journal:  Lancet HIV       Date:  2020-03-05       Impact factor: 12.767

10.  Development and Calibration of a Dynamic HIV Transmission Model for 6 US Cities.

Authors:  Xiao Zang; Emanuel Krebs; Jeong E Min; Ankur Pandya; Brandon D L Marshall; Bruce R Schackman; Czarina N Behrends; Daniel J Feaster; Bohdan Nosyk
Journal:  Med Decis Making       Date:  2019-12-22       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.